Short-Term Dual Antiplatelet and Maintenance CloPidogrel Therapy After Drug-Eluting Stent Implantation
Status:
Terminated
Trial end date:
2017-02-13
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare short-term (6-month Dual Anti Platelet Therapy(DAPT)
followed by clopidogrel monotherapy) vs. standard long-term dual antiplatelet strategies
(24-month DAPT followed by aspirin monotherapy) on clinically relevant bleeding complications
(Bleeding Academic Research Consortium(BARC) type 2, 3, or 5)31 in patients after
zotarolimus-eluting stent implantation.
Phase:
Phase 4
Details
Lead Sponsor:
CHEOL WHAN LEE, M.D., Ph.D
Collaborators:
CardioVascular Research Foundation, Korea Chong Kun Dang Pharmaceutical Corp. Medtronic